Laura Pastorino

Prof. Laura Pastorino


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Biomaterials
Verified
Journal Article
Closed access
MTMaria Teresa Tedesco
Maria Teresa Tedesco
DLDonatella Di Lisa
Donatella Di Lisa
PMPaolo Massobrio
Paolo Massobrio
NCNicolò Colistra
Nicolò Colistra
MPMattia Pesce
Mattia Pesce
LPLaura Pastorino
Laura Pastorino

1 September 2004 in Enzyme and Microbial Technology
Verified
Journal Article
Closed access
LPLaura Pastorino
Laura Pastorino
FPFranco Pioli
Franco Pioli
MZMario Zilli
Mario Zilli
Attilio ConvertiAttilio Converti
Attilio Converti
CNClaudio Nicolini
Claudio Nicolini

1 August 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SBStefania Boi
Stefania Boi
NRNadia Rouatbi
Nadia Rouatbi
EDElena Dellacasa
Elena Dellacasa
DLDonatella Di Lisa
Donatella Di Lisa
PBPaolo Bianchini
Paolo Bianchini
LPLaura Pastorino
Laura Pastorino

1 April 2018 in Polymers
Verified
Journal Article
Open access
PDF file
AMAlessandra Marrella
Alessandra Marrella
ALAlberto Lagazzo
Alberto Lagazzo
EDElena Dellacasa
Elena Dellacasa
CPCamilla Pasquini
Camilla Pasquini
Elisabetta FinocchioElisabetta Finocchio
Elisabetta Finocchio
Silvia ScaglioneSilvia Scaglione
Silvia Scaglione
One of the current major challenges in orthopedic surgery is the treatment of meniscal lesions. Some of the main issues include mechanical consistency of meniscal implants, besides their fixation methods and integration with the host tissues. To tackle these aspects we realized a micro-porous, gelatin/polyvinyl alcohol (PVA)-based hydrogel to approach the high percentage of water present in the native meniscal tissue, recapitulating its biomechanical features, and, at the same time, realizing a porous implant, permissive to cell infiltration and tissue integration. In particular, we adopted aerodynamically-assisted jetting technology to realize sodium alginate micro-particles with controlled dimensions to be used as porogens. The porous hydrogels were realized through freezing-thawing cycles, followed by alginate particles leaching. Composite hydrogels showed a high porosity (74%) and an open porous structure, while preserving the elasticity behavior (E = 0.25 MPa) and high water content, typical of PVA-based hydrogels. The ex vivo animal model validation proved that the addition of gelatin, combined with the micro-porosity of the hydrogel, enhanced implant integration with the host tissue, allowing penetration of host cells within the construct boundaries. Altogether, these results show that the combined use of a water-insoluble micro-porogen and gelatin, as a bioactive agent, allowed the realization of a porous composite PVA-based hydrogel to be envisaged as a potential meniscal substitute.

5 July 2019 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
DPDaniela Peneda Pacheco
Daniela Peneda Pacheco
CBCosmin Butnarasu
Cosmin Butnarasu
BFBriatico-Vangosa Francesco
Briatico-Vangosa Francesco
LPLaura Pastorino
Laura Pastorino
LVLivia Visai
Livia Visai
Paola PetriniPaola Petrini
Paola Petrini
Mucus is a natural barrier with a protective role that hinders drug diffusion, representing a steric and interactive barrier to overcome for an effective drug delivery to target sites. In diseases like cystic fibrosis (CF), pulmonary mucus exhibits altered features, which hamper clearance mechanisms and drug diffusion, ultimately leading to lung failure. Effectively modelling the passage through mucus still represents an unmet challenge. An airway CF mucus model is herein proposed to disassemble the complexity of the mucus barrier following a modular approach. A hydrogel, mainly composed of mucin in an alginate (Alg) network, is proposed to specifically model the chemical–physical properties of CF mucus. The steric retention of pathological mucus was reproduced by targeting its mesh size (approximately 50 nm) and viscoelastic properties. The interactive barrier was reproduced by a composition inspired from the CF mucus. Optimized mucus models, composed of 3 mg ml−1 Alg and 25 mg ml−1 mucin, exhibited a G′ increasing from ∼21.2 to 55.2 Pa and a G′′ ranging from ∼5.26 to 28.8 Pa in the frequency range of 0.1 to 20 Hz. Drug diffusion was tested using three model drugs. The proposed mucus model was able to discriminate between the mucin–drug interaction and the steric barrier of a mucus layer with respect to the parallel artificial membrane permeability (PAMPA) that models the phospholipidic cell membrane, the state-of-the-art screening tool for passive drug diffusion. The mucus model can be proposed as an in vitro tool for early drug discovery, representing a step forward to model the mucus layer. Additionally, the proposed methodology allows to easily include other molecules present within mucus, as relevant proteins, lipids and DNA.

12 June 2023 in Gels
Verified
Journal Article
Open access
PDF file
IPIlaria Parodi
Ilaria Parodi
DLDonatella Di Lisa
Donatella Di Lisa
LPLaura Pastorino
Laura Pastorino
Silvia ScaglioneSilvia Scaglione
Silvia Scaglione
MFMarco Massimo Fato
Marco Massimo Fato
In vitro three-dimensional models aim to reduce and replace animal testing and establish new tools for oncology research and the development and testing of new anticancer therapies. Among the various techniques to produce more complex and realistic cancer models is bioprinting, which allows the realization of spatially controlled hydrogel-based scaffolds, easily incorporating different types of cells in order to recreate the crosstalk between cancer and stromal components. Bioprinting exhibits other advantages, such as the production of large constructs, the repeatability and high resolution of the process, as well as the possibility of vascularization of the models through different approaches. Moreover, bioprinting allows the incorporation of multiple biomaterials and the creation of gradient structures to mimic the heterogeneity of the tumor microenvironment. The aim of this review is to report the main strategies and biomaterials used in cancer bioprinting. Moreover, the review discusses several bioprinted models of the most diffused and/or malignant tumors, highlighting the importance of this technique in establishing reliable biomimetic tissues aimed at improving disease biology understanding and high-throughput drug screening.